• SENSEX 81,028.02
    1,718.01 (+2.17%)
  • BANKNIFTY 59,086.00
    1,312.35 (+2.27%)
  • Billionbrains
    208.75 112.02(%)
  • Lenskart Solut.
    733.10 767.40(%)
  • NSE
    1,953.95 1,953.95(%)
  • Cartrade Tech
    2,712.90 3,291.35(%)
  • Apar Inds.
    13,783.50 6,800.00(%)
  • Tonbo Imaging
    1,427.75 1,013.95(%)
  • M & M
    3,295.00 3,840.00(%)
  • Cummins India
    3,903.00 3,883.30(%)
  • HDFC Bank
    787.00 1,017.90(%)
  • ICICI Bank
    1,569.30 1,569.30(%)
  • Sai Life
    1,815.55 1,815.55(%)
  • Hitachi Energy
    26,720.00 16,104.00(%)
  • Avenue Super.
    3,408.40 3,104.00(%)
  • Axis Bank
    1,323.90 1,418.30(%)
  • Bharti Airtel
    2,120.00 2,174.70(%)
  • Larsen & Toubro
    4,118.90 4,440.00(%)
  • Jio Platforms
    1,390.00 1,356.40(%)
  • CG Power & Ind
    734.00 525.50(%)
  • Reliance Industries
    1,318.10 1,611.20(%)
  • SBI
    1,020.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

ERIS Lifesciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 66197.0
  • ISIN : INE406M01024
1,234.10 4 (0.34%)
  • As on 07 Nov 2026 (EOD)

  • Today’s Low

    1,216.10

  • Today’s High

    1,237.90

  • Open

    1,234.70

  • Perv Close

    1,229.90

  • 52W Low

    1,069.00

  • 52W High

    1,740.00

Key Indicators

  • P/E(TTM)

    79.23

  • Mar.Cap (₹Cr.)

    17,121.73

  • Div & Yield %

    0.58

  • Book Value(₹)

    237.02

  • Debt-Equity Ratio

    0.34

  • AGM Date

    06-Nov-2026

  • EPS

    15.55

  • P/E Ratio

    79.23

Financials Ratios

  • Debt-Equity Ratio

    0.76

  • Mar.Cap (₹Cr.)

    17,121.73

  • RONW (%)

    16.61

  • ROCE (%)

    12.06

Score Board

  • Equity (₹ in Cr.)

    13.87

  • BV (₹)

    237.00

  • Sales( ₹ in Cr.)

    1,821.74

  • NP (in Cr.)

    253.51

  • NP Var(%)

    233.0

  • Div%

    721.0

  • CPS (₹)

    29.40

  • EPS (₹)

    18.30

  • Traded Value (₹ in Lakhs)

    17,093.29

  • 52 Week High

    1,740.00

  • 52 Week Low

    1,069.00

  • Price BSE

    1232.0

  • Price NSE

    1,234.00

  • Market Capital( in Cr.)

    17,093.29

  • P/C Ratio

    41.90

  • P/E Ratio

    67.40

  • Price Vs.BV

    18.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,821.74 1,697.75 1,528.28 1,340.37 1,215.73 1,108.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,821.74 1,697.75 1,528.28 1,340.37 1,215.73 1,108.83
Other Income 98.31 35.51 34.83 17.26 28.99 10.00
Stock Adjustments -64.49 43.54 13.15 -8.50 -2.49 12.57
Total Income 1,855.56 1,776.80 1,576.26 1,349.13 1,242.23 1,131.40
EXPENDITURE :            
Raw Materials 562.21 542.79 293.31 227.88 197.16 211.08
Power and Fuel Cost 3.50 4.10 4.46 4.41 4.01 3.89
Employee Cost 340.62 361.92 331.67 252.52 220.11 207.02
Other Manufacturing Expenses 25.38 25.46 16.80 11.50 7.47 7.16
Selling and Administration Expenses 123.96 214.41 319.27 242.67 215.51 181.66
Miscellaneous Expenses 103.92 106.06 122.10 87.78 84.93 93.13
Employee Benefit Expenses 340.62 361.92 331.67 252.52 220.11 207.02
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,159.59 1,254.74 1,087.61 826.75 729.18 703.93
Operating Profit 695.97 522.06 488.65 522.38 513.04 427.47
Interest 179.54 220.24 57.42 20.81 3.05 0.94
Gross Profit 516.43 301.82 431.23 501.57 509.99 426.53
Depreciation 154.38 181.77 102.39 64.66 51.46 37.64
Profit Before Tax 362.05 120.05 328.84 436.91 458.53 388.89
Current Tax 60.96 21.98 57.64 76.50 80.17 70.18
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 57.04 20.68 -28.52 -37.59 -38.83 -31.90
Reported Net Profit 244.05 77.39 299.72 398.01 417.19 350.61
Extraordinary Items -9.46 2.83 2.79 5.17 -1.72 2.33
Adjusted Net Profit 253.51 74.56 296.93 392.84 418.91 348.28
Adjustment below Net Profit 0.69 -2.84 -2.76 -0.15 -1.01 -1.28
P & L Balance brought forward 2,461.66 2,487.17 2,190.21 1,892.28 1,557.74 1,283.09
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 100.06 0.00 99.93 81.65 74.68
P & L Balance carried down 2,706.40 2,461.66 2,487.17 2,190.21 1,892.28 1,557.74
Dividend 0.00 0.00 0.00 99.93 81.65 74.68
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 721.00 735.00 0.00 735.00 601.00 550.00
Dividend Per Share(Rs) 7.21 7.35 0.00 7.35 6.01 5.50
Earnings Per Share-Unit Curr 17.62 5.68 22.04 29.27 30.69 25.82
Earnings Per Share(Adj)-Unit Curr 17.62 5.68 22.04 29.27 30.69 25.82
Book Value 230.72 184.65 185.59 163.39 141.11 116.03
Book Value(Adj)-Unit Curr 230.72 184.65 185.59 163.39 141.11 116.03

Shareholding Pattern

  • Promoter Group

    54.74%

  • Public Share Holding

    45.26%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 75,945,236 54.74 75,945,236 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 75,945,236 54.74 75,945,236 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 10 0.00 10 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3 0.00 3 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,965,883 5.74 7,965,883 131
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,123,539 1.53 2,123,539 6
Mutual Funds / UTI 24,948,993 17.98 24,948,993 18
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 950,344 0.69 950,344 16
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 35,988,772 25.94 35,988,772 173
2] Non Institution
Bodies Corporate 442,233 0.32 442,233 249
Clearing Members 27,117 0.02 27,117 17
Directors of their Relatives 154,310 0.11 154,310 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 214,392 0.15 214,392 1,205
Foreign Non Institution Other 11,965,882 8.62 11,965,882 1
Hindu Undivided Families 88,755 0.06 88,755 1,035
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,319,584 7.44 10,319,584 5
Individuals holding nominal share capital up to Rs. 1 lakh 3,467,890 2.50 3,467,890 46,307
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,002 0.00 2,002 2
Others 66,870 0.05 66,870 2
Sub Total 26,804,561 19.32 26,804,561 48,856
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 138,738,569 100.00 138,738,569 49,034

Company Background

ERIS Lifesciences LtdPharmaceuticals - Indian - Formulations

  • ERIS Lifesciences Ltd
  • BSE Code : 66197.0
  • ISIN : INE406M01024

  • Incorporation Year

    2007

  • Registered Office

    8th Floor Commerce House -IV
    Prahladnagar 100 FT Road, Ahmedabad,
    Gujarat-380015

  • Telephone

    91-79-30451000

  • FAX

    91-79-48903474

  • Chairman

    Amit Indubhushan Bakshi

  • Managing Director

    Amit Indubhushan Bakshi

  • Company Secretary

    Milind Talegaonkar

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

ERIS Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
ERIS Lifescience 1,232.05 1,920.05 1,821.74 99.44 10.66
Abbott India 26,340.05 7,217.19 6,929.05 34.66 43.78
Astrazeneca Phar 6,387.90 2,304.07 2,275.58 94.15 27.86
Glaxosmi. Pharma 2,524.85 3,932.76 3,790.20 37.52 58.17
Evonile Pharma 1,762.40 393.10 354.33 -1,087.90 15.94
Cipla 1,409.00 20,102.60 18,979.95 42.94 13.88
Bliss GVS Pharma 603.40 773.53 729.81 39.34 12.51
Amrutanjan Healt 513.30 520.13 502.55 25.90 24.16
Fermenta Biotec. 447.05 474.15 450.25 20.87 18.77
Guj. Themis Bio. 379.05 168.25 165.82 101.35 18.05
Ambalal Sarabhai 35.25 19.52 3.94 65.28 6.77